文献速递神经肿瘤

SEER-Medicaid与SEER-Medicare数据在神经肿瘤研究中的应用

SEER-Medicaid and SEER-Medicare data for neuro-oncology research.
PubMed 文献 · J Neurooncol · 2026-02-10

本文叙述性综述了SEER-Medicaid与SEER-Medicare数据资源,总结其数据结构、链接机制、申请流程及在神经肿瘤研究中的潜在用途、优势与局限。两数据库为研究脑肿瘤患者的医疗可及性、治疗模式、服务利用和结局提供丰富机会,但目前用于神经肿瘤研究仍有限,尤其对低收入和老年患者群体有重要价值。

要点

  • SEER-Medicaid与SEER-Medicare是神经肿瘤研究中尚未充分利用的宝贵资源。
  • 两数据库可支持脑肿瘤诊疗全流程的公平性与结局研究。
  • 尤其适用于低收入和老年脑肿瘤患者群体的政策相关研究。

核心结论

  • SEER-Medicaid与SEER-Medicare是神经肿瘤领域有价值但尚未充分利用的数据资源。

研究设计与样本

  • 本文为叙述性综述,总结SEER-Medicaid与SEER-Medicare的数据结构、链接机制、数据可及性、申请流程及在神经肿瘤研究中的潜在用途与局限。

主要发现

  • 两数据库为研究脑肿瘤人群的医疗可及性、治疗模式、服务利用和结局提供丰富机会。
  • 目前利用这些数据资源开展的神经肿瘤研究仍有限。

临床怎么用

  • 研究者可借助两数据库开展脑肿瘤诊疗全流程的流行病学与政策相关研究。
  • 尤其可关注低收入和老年脑肿瘤患者的公平性与结局问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Surveillance, Epidemiology, and End Results (SEER) program is a robust resource for U.S. cancer surveillance, capturing cancer patient data on diagnosis, treatment, survival, and demographics across diverse population-based cancer registries. The linkage of SEER data with Medicare and, more recently, Medicaid, enhances its utility for understanding treatment access, quality, and outcomes, as well as health policy impacts, on patients with brain tumors. This review describes the SEER-Medicaid and SEER-Medicare data resources and provides practical guidance for researchers to support robust epidemiologic and policy-relevant neuro-oncology investigations. METHODS: We conducted a narrative review of SEER-Medicaid and SEER-Medicare resources, summarizing data structures, linkage mechanisms, data availability, application process, potential uses for neuro-oncology research with examples, strengths and limitations for research, and future directions. RESULTS: Both SEER-Medicaid and SEER-Medicare offer rich opportunities to study access to care, treatment patterns, service utilization, and outcomes in brain tumor populations. However, the use of these data sources for neuro-oncology studies is limited to date. CONCLUSIONS: SEER-Medicaid and SEER-Medicare are valuable yet underused resources in neuro-oncology. These databases enable a broader set of questions across the brain tumor care continuum, particularly for low-income and older patients, with relevance for addressing equity and improving outcomes in neuro-oncology.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Johnson KJ, Brown DS, Johnston KJ, et al. SEER-Medicaid and SEER-Medicare data for neuro-oncology research. J Neurooncol. 2026. PMID: 41665824. doi:10.1007/s11060-025-05380-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。